RaPID 对 SARS-CoV-2 的回应

IF 2.3 4区 化学 Q3 CHEMISTRY, MULTIDISCIPLINARY
Sven Ullrich, Assoc. Prof. Christoph Nitsche
{"title":"RaPID 对 SARS-CoV-2 的回应","authors":"Sven Ullrich,&nbsp;Assoc. Prof. Christoph Nitsche","doi":"10.1002/ijch.202300170","DOIUrl":null,"url":null,"abstract":"<p>Genetically encoded peptide libraries are at the forefront of <i>de novo</i> drug discovery. The RaPID (Random Nonstandard Peptides Integrated Discovery) platform stands out due to the unique combination of flexible <i>in vitro</i> translation (FIT) and mRNA display. This enables the incorporation of non-canonical amino acids, improving chemical diversity and allowing macrocyclisation of the peptide library. The resulting constrained peptides are valued for their strong binding affinity and stability, especially in the context of protein-protein interactions. In response to SARS-CoV-2, the causative agent of the COVID-19 pandemic, the RaPID system proved valuable in identifying high-affinity ligands of viral proteins. Among many peptide ligands of SARS-CoV-2 spike and main protease (M<sup>pro</sup>), several macrocycles stand out for their exceptional binding affinities. Structural data showcases distinct binding modes in complex with the receptor-binding domain (RBD) of the spike glycoprotein or the catalytic active site of M<sup>pro</sup>. However, translating these <i>in vitro</i> findings into clinical applications remains challenging, especially due to insufficient cell permeability.</p>","PeriodicalId":14686,"journal":{"name":"Israel Journal of Chemistry","volume":"64 8-9","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijch.202300170","citationCount":"0","resultStr":"{\"title\":\"A RaPID Response to SARS-CoV-2\",\"authors\":\"Sven Ullrich,&nbsp;Assoc. Prof. Christoph Nitsche\",\"doi\":\"10.1002/ijch.202300170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Genetically encoded peptide libraries are at the forefront of <i>de novo</i> drug discovery. The RaPID (Random Nonstandard Peptides Integrated Discovery) platform stands out due to the unique combination of flexible <i>in vitro</i> translation (FIT) and mRNA display. This enables the incorporation of non-canonical amino acids, improving chemical diversity and allowing macrocyclisation of the peptide library. The resulting constrained peptides are valued for their strong binding affinity and stability, especially in the context of protein-protein interactions. In response to SARS-CoV-2, the causative agent of the COVID-19 pandemic, the RaPID system proved valuable in identifying high-affinity ligands of viral proteins. Among many peptide ligands of SARS-CoV-2 spike and main protease (M<sup>pro</sup>), several macrocycles stand out for their exceptional binding affinities. Structural data showcases distinct binding modes in complex with the receptor-binding domain (RBD) of the spike glycoprotein or the catalytic active site of M<sup>pro</sup>. However, translating these <i>in vitro</i> findings into clinical applications remains challenging, especially due to insufficient cell permeability.</p>\",\"PeriodicalId\":14686,\"journal\":{\"name\":\"Israel Journal of Chemistry\",\"volume\":\"64 8-9\",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-01-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijch.202300170\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Israel Journal of Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ijch.202300170\",\"RegionNum\":4,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Israel Journal of Chemistry","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijch.202300170","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

1 引言1.1 RaPID 平台和大环肽药物基因编码肽库已成为新药发现的强大资源。1, 2 这些肽库嵌入了最先进的展示技术,有助于从广阔的序列空间中识别高亲和性肽配体。对肽库进行化学修饰,包括加入非典型氨基酸,可以大大提高筛选出的肽的多样性和药物亲和性。4-6 因此,大多数肽展示都倾向于使用修饰的受限肽,而不是线性肽,7 因为它们具有有益的药物特性、10 大环肽具有多种拓扑结构,11-14 它们的结构特别适合模拟和破坏蛋白质与蛋白质之间的相互作用。15 同样,大环肽固有的刚性增强了它们的靶向亲和力和代谢稳定性、19 然而,大环肽的分子量相对较低,其合成可及性与小分子相似。11, 17 因此,约束肽在小分子和蛋白质疗法之间的 "金发区"(图 1)取得了平衡,6, 20 使其与未来的疗法开发高度相关、22-24 RaPID(随机非标准肽集成发现)平台25(图 2)有助于鉴定选择性和高亲和力结合肽大环26。RaPID 将 FIT 系统(柔性体外翻译)与 mRNA 显示技术巧妙地结合在一起。27 因此,flexizymes(柔性 tRNA-氨基酰化核酶)被用来实现非经典氨基酸的结合。28 通过这种方式,越来越多的非经典氨基酸成为特色,包括 N-甲基、d-、β- 和 γ-氨基酸。虽然各种环化化学反应与 mRNA 显示兼容,1、29、30 但在大多数 RaPID 筛选中,翻译始于氯乙酰化氨基酸,这些氨基酸在与半胱氨酸残基反应后形成硫醚连接。28 由于使用嘌呤霉素将翻译后的多肽与其遗传信息连接起来,因此可以通过测序恢复亲和性筛选富集多肽的信息、29 RaPID 平台已经为越来越多的靶标制备出高亲和性配体,10、26、28、31 因此被认为有能力为几乎任何给定的蛋白质制备大环配体32。SARS-CoV-2的出现以及由此引发的COVID-19大流行使得疫苗、药物和诊断工具的开发迫在眉睫。已确定了一系列与医学相关的病毒靶标37-42 ,其中大多数疫苗和药物相关研究都是针对尖峰糖蛋白(S)38 和主要蛋白酶(Mpro 或 3CLpro)进行的。同源三聚体嵌入病毒包膜,形成了冠状病毒的特有结构47 。它是病毒与宿主细胞融合不可或缺的部分,决定了 SARS-CoV-2 的宿主范围和趋向性48, 49 。在这一过程中,最重要的是受体结合域(RBD),它与 ACE2 受体结合以进入细胞50 。尖峰蛋白作为病毒进入的介质,加上其免疫原性,使尖峰蛋白成为成功疫苗开发活动中的一个常见元素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A RaPID Response to SARS-CoV-2

A RaPID Response to SARS-CoV-2

A RaPID Response to SARS-CoV-2

Genetically encoded peptide libraries are at the forefront of de novo drug discovery. The RaPID (Random Nonstandard Peptides Integrated Discovery) platform stands out due to the unique combination of flexible in vitro translation (FIT) and mRNA display. This enables the incorporation of non-canonical amino acids, improving chemical diversity and allowing macrocyclisation of the peptide library. The resulting constrained peptides are valued for their strong binding affinity and stability, especially in the context of protein-protein interactions. In response to SARS-CoV-2, the causative agent of the COVID-19 pandemic, the RaPID system proved valuable in identifying high-affinity ligands of viral proteins. Among many peptide ligands of SARS-CoV-2 spike and main protease (Mpro), several macrocycles stand out for their exceptional binding affinities. Structural data showcases distinct binding modes in complex with the receptor-binding domain (RBD) of the spike glycoprotein or the catalytic active site of Mpro. However, translating these in vitro findings into clinical applications remains challenging, especially due to insufficient cell permeability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Israel Journal of Chemistry
Israel Journal of Chemistry 化学-化学综合
CiteScore
6.20
自引率
0.00%
发文量
62
审稿时长
6-12 weeks
期刊介绍: The fledgling State of Israel began to publish its scientific activity in 1951 under the general heading of Bulletin of the Research Council of Israel, which quickly split into sections to accommodate various fields in the growing academic community. In 1963, the Bulletin ceased publication and independent journals were born, with Section A becoming the new Israel Journal of Chemistry. The Israel Journal of Chemistry is the official journal of the Israel Chemical Society. Effective from Volume 50 (2010) it is published by Wiley-VCH. The Israel Journal of Chemistry is an international and peer-reviewed publication forum for Special Issues on timely research topics in all fields of chemistry: from biochemistry through organic and inorganic chemistry to polymer, physical and theoretical chemistry, including all interdisciplinary topics. Each topical issue is edited by one or several Guest Editors and primarily contains invited Review articles. Communications and Full Papers may be published occasionally, if they fit with the quality standards of the journal. The publication language is English and the journal is published twelve times a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信